Aminomethanesulfonic acid, also known as sulfamic acid, is a white crystalline solid with a melting point of 205 °C. It is a strong monoprotic acid with a pKa of 1.0. It is a versatile compound with numerous applications in various industries. Sulfamic acid is synthesized by the reaction of urea with sulfur trioxide. It is an effective cleaning agent, particularly for removing mineral deposits and rust. In the chemical industry, it is used as a reagent in the synthesis of various organic compounds, such as herbicides, pharmaceuticals, and dyes. Sulfamic acid is also used as a flame retardant, a catalyst, and a stabilizer. It is also a key ingredient in some denture cleaners. Sulfamic acid is a widely studied compound due to its wide range of applications and potential for further development in various fields.'
| ID Source | ID |
|---|---|
| PubMed CID | 83791 |
| CHEMBL ID | 1741886 |
| SCHEMBL ID | 1479882 |
| SCHEMBL ID | 151552 |
| MeSH ID | M0133257 |
| Synonym |
|---|
| unii-jq5rq6235b |
| einecs 230-076-2 |
| jq5rq6235b , |
| NCI60_003721 |
| 6939-85-1 |
| nsc-39851 |
| nsc-209983 |
| aminomethanesulphonic acid |
| nsc209983 |
| NCGC00013463 |
| (aminomethyl)sulfonic acid |
| 13881-91-9 |
| aminomethanesulfonic acid |
| methanesulfonic acid, amino- |
| NSC39851 , |
| aminomethanesulfonic acid, 97% |
| NCI39851 |
| NCISTRUC2_000162 |
| NCISTRUC1_001902 |
| NCGC00096578-01 |
| sodium aminomethanesulphonate |
| A0852 |
| azanylmethanesulfonic acid |
| A807447 |
| methanesulfonic acid, 1-amino- |
| nsc 209983 |
| einecs 237-649-6 |
| ola224z482 , |
| nsc 39851 |
| ai3-62913 |
| unii-ola224z482 |
| SCHEMBL1479882 |
| AKOS006223914 |
| CCG-37664 |
| NCGC00013463-02 |
| FT-0622294 |
| STL373553 |
| aminomethylsulfonic acid |
| SCHEMBL151552 |
| BBL027684 |
| DTXSID2065670 |
| aminomethanesulfonicacid |
| CHEMBL1741886 |
| mfcd00008124 |
| AC-9853 |
| J-007180 |
| F0001-0476 |
| E75772 |
| AS-12994 |
| EN300-101762 |
| AMY8974 |
| Q27285722 |
| SY049304 |
| CS-W016624 |
| L2L , |
| Excerpt | Relevance | Reference |
|---|---|---|
| " The rats were sacrificed at 24 h after a dosing with STZ under general anesthesia, and their brains and spinal cords collected by the freeze clamp technique." | ( The Effect of Taurine and Its Immediate Homologs on Diabetes-Induced Oxidative Stress in the Brain and Spinal Cord of Rats. Lau-Cam, CA; Patel, SN, ) | 0.13 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.67) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||